Alterations in Energy Metabolism, Neuroprotection and Visual Signal Transduction in the Retina of Parkinsonian, MPTP-Treated Monkeys

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Campello, Laura ^a   Esteve Rudd, Julián ^a,d   Bru Martínez, Roque ^a   Herrero, María Trinidad ^b,c   Fernández Villalba, Emiliano ^c   Cuenca, Nicolás ^a   Martín Nieto, José ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b UNIVERSITAT JAUME I   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA ENOLASE; BETA CRYSTALLIN; CALBINDIN; CYTOCHROME C OXIDASE; G PROTEIN COUPLED RECEPTOR; GAMMA SYNUCLEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 70; INORGANIC PYROPHOSPHATASE; NEURON SPECIFIC ENOLASE; NUCLEOSIDE DIPHOSPHATE KINASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RETINA S ANTIGEN; STATHMIN; TRANSDUCIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRESS; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME INHIBITION; GLYCOLYSIS; HAPLORHINI; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL ENERGY TRANSFER; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEOMICS; RETINA; RETINA NERVE CELL; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VISUAL STIMULATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ELECTRON TRANSPORT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; EYE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIGHT SIGNAL TRANSDUCTION; MACACA FASCICULARIS; MALE; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PROTEOMICS; RETINA;

EID: 84883515923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074439     Document Type: Article

References (124)

1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J, (2011) Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 26: S1-S58. doi:10.1007/s10654-010-9506-9. PubMed: 21626386.
2. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A, (2006) Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60: 389-398. doi:10.1002/ana.21022. PubMed: 17068789.
3. Herrero MT, Pagonabarraga J, Linazasoro G, (2011) Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. Neurologist 17: S54-S66. doi:10.1097/NRL.0b013e31823968fc. PubMed: 22045327.
4. Lansbury PT Jr., Brice A, (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Genet Dev 12: 299-306. doi:10.1016/S0959-437X(02)00302-7. PubMed: 12076673.
5. Thomas B, Beal MF, (2007) Parkinson's disease. Hum Mol Genet 16: R183-R194. doi:10.1093/hmg/ddm159. PubMed: 17911161.
6. Licker V, Kövari E, Hochstrasser DF, Burkhard PR, (2009) Proteomics in human Parkinson's disease research. J Proteomics 73: 10-29. doi:10.1016/j.jprot.2009.07.007. PubMed: 19632367.
7. Schober A, (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318: 215-224. doi:10.1007/s00441-004-0938-y. PubMed: 15503155.
8. Uversky VN, (2004) Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318: 225-241. doi:10.1007/s00441-004-0937-z. PubMed: 15258850.
9. Terzioglu M, Galter D, (2008) Parkinson's disease: genetic versus toxin-induced rodent models. FEBS J 275: 1384-1391. doi:10.1111/j.1742-4658.2008.06302.x. PubMed: 18279376.
10. Dawson TM, Ko HS, Dawson VL, (2010) Genetic animal models of Parkinson's disease. Neuron 66: 646-661. doi:10.1016/j.neuron.2010.04.034. PubMed: 20547124.
11. Lotharius J, Brundin P, (2002) Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum Mol Genet 11: 2395-2407. doi:10.1093/hmg/11.20.2395. PubMed: 12351575.
12. Campello L, Esteve-Rudd J, Cuenca N, Martín-Nieto J, (2013) The ubiquitin-proteasome system in retinal health and disease. Mol Neurobiol 47: 790-810. doi:10.1007/s12035-012-8391-5. PubMed: 23339020.
13. Clark J, Dai Y, Simon DK, (2011) Do somatic mitochondrial DNA mutations contribute to Parkinson's disease? Parkinsons Dis:(2011): pp. 659694.
14. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, et al. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279: 18614-18622. doi:10.1074/jbc.M401135200. PubMed: 14985362.
15. Nowacka B, Lubiński W, Karczewicz D, (2010) Ophthalmological and electrophysiological features of Parkinson's disease. Klin Oczna 112: 247-252. PubMed: 21117366.
16. Archibald NK, Clarke MP, Mosimann UP, Burn DJ, (2009) The retina in Parkinson's disease. Brain 132: 1128-1145. doi:10.1093/brain/awp068. PubMed: 19336464.
17. Bodis-Wollner I, (2009) Retinopathy in Parkinson Disease. J Neural Transm 116: 1493-1501. doi:10.1007/s00702-009-0292-z. PubMed: 19730784.
18. Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA, (1988) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111: 131-149. doi:10.1093/brain/111.1.131. PubMed: 3259150.
19. Ghilardi MF, Chung E, Bodis-Wollner I, Dvorzniak M, Glover A, et al. (1988) Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 43: 255-262. doi:10.1016/0024-3205(88)90315-3. PubMed: 3260986.
20. Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA, (1989) The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 25: 357-364. doi:10.1002/ana.410250407. PubMed: 2496639.
21. Cuenca N, Herrero M-T, Angulo A, De Juan E, Martínez-Navarrete GC, et al. (2005) Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease. J Comp Neurol 493: 261-273. doi:10.1002/cne.20761. PubMed: 16255027.
22. Esteve-Rudd J, Fernández-Sánchez L, Lax P, De Juan E, Martín-Nieto J, et al. (2011) Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina. Neurobiol Dis 44: 102-115. doi:10.1016/j.nbd.2011.06.009. PubMed: 21742033.
23. Barcia C, Bautista V, Sánchez-Bahillo A, Fernández-Villalba E, Navarro-Ruis JM, et al. (2003) Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys. Neuroendocrinology 78: 118-128. doi:10.1159/000071967. PubMed: 12915764.
24. Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE, (2000) Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods 96: 71-76. doi:10.1016/S0165-0270(99)00184-3. PubMed: 10704673.
25. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44. doi:10.1002/pmic.200390006. PubMed: 12548632.
26. Heukeshoven J, Dernick R, (1985) Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6: 103-112. doi:10.1002/elps.1150060302.
27. Neuhoff V, Arold N, Taube D, Ehrhardt W, (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262. doi:10.1002/elps.1150090603. PubMed: 2466658.
28. Sellés-Marchart S, Luque I, Casado-Vela J, Martínez-Esteso MJ, Bru-Martínez R, (2008) Proteomics of multigenic families from species underrepresented in databases: the case of loquat (Eriobotrya japonica Lindl.) polyphenol oxidases. J Proteome Res 7: 4095-4106. doi:10.1021/pr700687c. PubMed: 18620449.
29. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS, (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567. Available: http://www.matrixscience.com. doi:10.1002/(SICI)1522-2683(19991201)20:18. PubMed: 10612281.
30. Pappin DJ, Hojrup P, Bleasby AJ, (1993) Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3: 327-332. doi:10.1016/0960-9822(93)90195-T. PubMed: 15335725.
31. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N, (2007) α-Synuclein gene expression profile in the retina of vertebrates. Mol Vis 13: 949-961. PubMed: 17653035.
32. Esteve-Rudd J, Campello L, Herrero MT, Cuenca N, Martín-Nieto J, (2010) Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res 1352: 70-82. doi:10.1016/j.brainres.2010.07.019. PubMed: 20638372.
33. Rasband W, (2006) ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA. Available: http://rsb.info.nih.gov/ij.
34. Dancík V, Addona TA, Clauser KR, Vath JE, Pevzner PA, (1999) De novo peptide sequencing via tandem mass spectrometry. J Comput Biol 6: 327-342. doi:10.1089/106652799318300. PubMed: 10582570.
35. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25: 25-29. (URL http://www.geneontology.org. doi:10.1038/75556. PubMed: 10802651.
36. Hargrave PA, McDowell JH, (1992) Rhodopsin and phototransduction: a model system for G protein-linked receptors. FASEB J 6: 2323-2331. PubMed: 1544542.
37. Muchowski PJ, Wacker JL, (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6: 11-22. doi:10.1038/nrn1587. PubMed: 15611723.
38. Fort PE, Lampi KJ, (2011) New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp Eye Res 92: 98-103. doi:10.1016/j.exer.2010.11.008. PubMed: 21115004.
39. Liedtke W, Leman EE, Fyffe RE, Raine CS, Schubart UK, (2002) Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol 160: 469-480. doi:10.1016/S0002-9440(10)64866-3. PubMed: 11839567.
40. Tran CT, Leiper JM, Vallance P, (2003). The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4: 33-40. doi:10.1016/S1567-5688(03)90140-1.
41. Hattori T, Takei N, Mizuno Y, Kato K, Kohsaka S, (1995) Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci Res 21: 191-198. doi:10.1016/0168-0102(94)00849-B. PubMed: 7753500.
42. Goldenberg-Cohen N, Raiter A, Gaydar V, Dratviman-Storobinsky O, Goldstein T, et al. (2012) Peptide-binding GRP78 protects neurons from hypoxia-induced apoptosis. Apoptosis 17: 278-288. doi:10.1007/s10495-011-0678-x. PubMed: 22120956.
43. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, et al. (2005) S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665-674. doi:10.1038/ncb1268. PubMed: 15951807.
44. Andrade J, Pearce ST, Zhao H, Barroso M, (2004) Interactions among p22, glyceraldehyde-3-phosphate dehydrogenase and microtubules. Biochem J 384: 327-336. doi:10.1042/BJ20040622. PubMed: 15312048.
45. German DC, Manaye KF, Sonsalla PK, Brooks BA, (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 648: 42-62. doi:10.1111/j.1749-6632.1992.tb24523.x. PubMed: 1353337.
46. Lutz W, Frank EM, Craig TA, Thompson R, Venters RA, et al. (2003) Calbindin D28K interacts with Ran-binding protein M: identification of interacting domains by NMR spectroscopy. Biochem Biophys Res Commun 303: 1186-1192. doi:10.1016/S0006-291X(03)00499-6. PubMed: 12684061.
47. Agou F, Raveh S, Mesnildrey S, Véron M, (1999) Single strand DNA specificity analysis of human nucleoside diphosphate kinase B. J Biol Chem 274: 19630-19638. doi:10.1074/jbc.274.28.19630. PubMed: 10391900.
48. Ridge KD, Abdulaev NG, Sousa M, Palczewski K, (2003) Phototransduction: crystal clear. Trends Biochem Sci 28: 479-487. doi:10.1016/S0968-0004(03)00172-5. PubMed: 13678959.
49. Buchman VL, Adu J, Pinõn LG, Ninkina NN, Davies AM, (1998) Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci 1: 101-103. doi:10.1038/349. PubMed: 10195122.
50. Ninkina N, Peters O, Millership S, Salem H, Van der Putten H, et al. (2009) γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Hum Mol Genet 18: 1779-1794. doi:10.1093/hmg/ddp090. PubMed: 19246516.
51. Chiquet C, Dkhissi-Benyahya O, Chounlamountri N, Szel A, Degrip WJ, et al. (2002) Characterization of calbindin-positive cones in primates. Neuroscience 115: 1323-1333. doi:10.1016/S0306-4522(02)00327-5. PubMed: 12453500.
52. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, et al. (2004) Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4: 3943-3952. doi:10.1002/pmic.200400848. PubMed: 15526345.
53. De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P, (2005) A proteomic approach in the study of an animal model of Parkinson's disease. Clin Chim Acta 357: 202-209. doi:10.1016/j.cccn.2005.03.028. PubMed: 15946658.
54. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, et al. (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 134: 119-138. doi:10.1016/j.molbrainres.2004.10.003. PubMed: 15790536.
55. Periquet M, Corti O, Jacquier S, Brice A, (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 95: 1259-1276. doi:10.1111/j.1471-4159.2005.03442.x. PubMed: 16150055.
56. Kim SH, Vlkolinsky R, Cairns N, Lubec G, (2000) Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Cell Mol Life Sci 57: 1810-1816. doi:10.1007/PL00000661. PubMed: 11130185.
57. Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G, (2001) Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 280: 249-258. doi:10.1006/bbrc.2000.4109. PubMed: 11162507.
58. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, et al. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J Neurochem 82: 1524-1532. doi:10.1046/j.1471-4159.2002.01103.x. PubMed: 12354300.
59. Yang S, Liu T, Li S, Zhang X, Ding Q, et al. (2008) Comparative proteomic analysis of brains of naturally aging mice. Neuroscience 154: 1107-1120. doi:10.1016/j.neuroscience.2008.04.012. PubMed: 18495355.
60. Vorum H, Østergaard M, Rice GE, Honoré B, Bek T, (2007) Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis-a proteomic study. Proteome Sci 5: 5. doi:10.1186/1477-5956-5-5. PubMed: 17326818.
61. Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA, (2006) The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 2280-2290. doi:10.1167/iovs.05-1395. PubMed: 16723435.
62. Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, et al. (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 815-822. doi:10.1167/iovs.05-0976. PubMed: 16505012.
63. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA, (2008) Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 2848-2855. doi:10.1167/iovs.07-1352. PubMed: 18344451.
64. Tezel G, Yang X, Cai J, (2005) Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 46: 3177-3187. doi:10.1167/iovs.05-0208. PubMed: 16123417.
65. Wang YD, Wu JD, Jiang ZL, Wang YB, Wang XH, et al. (2007) Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis. Curr Eye Res 32: 891-901. doi:10.1080/02713680701593702. PubMed: 17963109.
66. Fort PE, Freeman WM, Losiewicz MK, Singh RS, Gardner TW, (2009) The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin. Mol Cell Proteomics 8: 767-779. doi:10.1074/mcp.M800326-MCP200. PubMed: 19049959.
67. Liu SQ, Kang J, Li CJ, Tang EJ, Wen B, et al. (2007) Differences in expression of retinal proteins between diabetic and normal rats. World J Gastroenterol 13: 2118-2124. PubMed: 17465459.
68. VanGuilder HD, Bixler GV, Kutzler L, Brucklacher RM, Bronson SK, et al. (2011) Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLOS ONE 6: e16271. doi:10.1371/journal.pone.0016271. PubMed: 21249158.
69. Keller A, Bérod A, Dussaillant M, Lamandé N, Gros F, et al. (1994) Coexpression of alpha and gamma enolase genes in neurons of adult rat brain. J Neurosci Res 38: 493-504. doi:10.1002/jnr.490380503. PubMed: 7815469.
70. Johnsson P, Blomquist S, Lührs C, Malmkvist G, Alling C, et al. (2000) Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 69: 750-754. doi:10.1016/S0003-4975(99)01393-4. PubMed: 10750755.
71. Hattori T, Ohsawa K, Mizuno Y, Kato K, Kohsaka S, (1994) Synthetic peptide corresponding to 30 amino acids of the C-terminal of neuron-specific enolase promotes survival of neocortical neurons in culture. Biochem Biophys Res Commun 202: 25-30. doi:10.1006/bbrc.1994.1888. PubMed: 8037719.
72. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608. doi:10.1038/33416. PubMed: 9560156.
73. Kapphahn RJ, Giwa BM, Berg KM, Roehrich H, Feng X, et al. (2006) Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets. Exp Eye Res 83: 165-175. doi:10.1016/j.exer.2005.11.017. PubMed: 16530755.
74. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, et al. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85: 1394-1401. doi:10.1046/j.1471-4159.2003.01786.x. PubMed: 12787059.
75. Greene JG, Dingledine R, Greenamyre JT, (2010) Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents. Neurobiol Dis 38: 476-481. doi:10.1016/j.nbd.2010.03.014. PubMed: 20307667.
76. Herrero-Mendez A, Almeida A, Fernández E, Maestre C, Moncada S, et al. (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11: 747-752. doi:10.1038/ncb1881. PubMed: 19448625.
77. Schapira AH, (1998) Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta 1364: 261-270. doi:10.1016/S0005-2728(98)00032-2. PubMed: 9593927.
78. Atamna H, Frey WH 2nd, (2007) Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 7: 297-310. doi:10.1016/j.mito.2007.06.001. PubMed: 17625988.
79. Ferrer I, Perez E, Dalfó E, Barrachina M, (2007) Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci Lett 415: 205-209. doi:10.1016/j.neulet.2007.01.026. PubMed: 17284347.
80. Chin MH, Qian WJ, Wang H, Petyuk VA, Bloom JS, et al. (2008) Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. J Proteome Res 7: 666-677. doi:10.1021/pr070546l. PubMed: 18173235.
81. Kolakowski LF Jr., Schloesser M, Cooperman BS, (1988) Cloning, molecular characterization and chromosome localization of the inorganic pyrophosphatase (PPA) gene from S. cerevisiae. Nucleic Acids Res 16: 10441-10452. doi:10.1093/nar/16.22.10441. PubMed: 2849749.
82. Curbo S, Lagier-Tourenne C, Carrozzo R, Palenzuela L, Lucioli S, et al. (2006) Human mitochondrial pyrophosphatase: cDNA cloning and analysis of the gene in patients with mtDNA depletion syndromes. Genomics 87: 410-416. doi:10.1016/j.ygeno.2005.09.017. PubMed: 16300924.
83. Dean DO, Kent CR, Tytell M, (1999) Constitutive and inducible heat shock protein 70 immunoreactivity in the normal rat eye. Invest Ophthalmol Vis Sci 40: 2952-2962. PubMed: 10549657.
84. Bernstein SL, Liu AM, Hansen BC, Somiari RI, (2000) Heat shock cognate-70 gene expression declines during normal aging of the primate retina. Invest Ophthalmol Vis Sci 41: 2857-2862. PubMed: 10967038.
85. Yu Q, Kent CR, Tytell M, (2001) Retinal uptake of intravitreally injected Hsc/Hsp70 and its effect on susceptibility to light damage. Mol Vis 7: 48-56. PubMed: 11239246.
86. Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, et al. (1999) Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1: 479-485. doi:10.1038/70265. PubMed: 10587643.
87. Yu Z, Luo H, Fu W, Mattson MP, (1999) The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp Neurol 155: 302-314. doi:10.1006/exnr.1998.7002. PubMed: 10072306.
88. Inokuchi Y, Nakajima Y, Shimazawa M, Kurita T, Kubo M, et al. (2009) Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest Ophthalmol Vis Sci 50: 334-344. PubMed: 18757512.
89. Li J, Wang JJ, Yu Q, Wang M, Zhang SX, (2009) Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett 583: 1521-1527. doi:10.1016/j.febslet.2009.04.007. PubMed: 19364508.
90. Hauck SM, Schoeffmann S, Deeg CA, Gloeckner CJ, Swiatek-de Lange M, et al. (2005) Proteomic analysis of the porcine interphotoreceptor matrix. Proteomics 5: 3623-3636. doi:10.1002/pmic.200401223. PubMed: 16127731.
91. Nookala S, Gandrakota R, Wohabrebbi A, Wang X, Howell D, et al. (2010) In search of the identity of the XAP-1 antigen: a protein localized to cone outer segments. Invest Ophthalmol Vis Sci 51: 2736-2743. doi:10.1167/iovs.09-4286. PubMed: 20042652.
92. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, et al. (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517. doi:10.1038/nature04782. PubMed: 16724068.
93. Danielson SR, Andersen JK, (2008) Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic Biol Med 44: 1787-1794. doi:10.1016/j.freeradbiomed.2008.03.005. PubMed: 18395015.
94. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, et al. (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304: 1328-1331. doi:10.1126/science.1093891. PubMed: 15105460.
95. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, et al. (2004) Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 101: 10810-10814. doi:10.1073/pnas.0404161101. PubMed: 15252205.
96. Blanchard-Fillion B, Souza JM, Friel T, Jiang GC, Vrana K, et al. (2001) Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J Biol Chem 276: 46017-46023. doi:10.1074/jbc.M105564200. PubMed: 11590168.
97. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, et al. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2: 1017-1021. doi:10.1038/nm0996-1017. PubMed: 8782460.
98. Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF, (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64: 936-939. PubMed: 7530297.
99. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, et al. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5: 1403-1409. doi:10.1038/70978. PubMed: 10581083.
100. Evans P, Slingsby C, Wallace BA, (2008) Association of partially folded lens βB2-crystallins with the α-crystallin molecular chaperone. Biochem J 409: 691-699. doi:10.1042/BJ20070993. PubMed: 17937660.
101. Xi J, Farjo R, Yoshida S, Kern TS, Swaroop A, et al. (2003) A comprehensive analysis of the expression of crystallins in mouse retina. Mol Vis 9: 410-419. PubMed: 12949468.
102. Saraswathy S, Rao NA, (2009) Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress. Invest Ophthalmol Vis Sci 50: 5559-5566. doi:10.1167/iovs.08-2842. PubMed: 19578012.
103. Liedtke T, Schwamborn JC, Schröer U, Thanos S, (2007) Elongation of axons during regeneration involves retinal crystallin β b2 (crybb2). Mol Cell Proteomics 6: 895-907. doi:10.1074/mcp.M600245-MCP200. PubMed: 17264069.
104. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ, (2000) Identification by array screening of altered nm23-M2/PuF mRNA expression in mouse retinal degeneration. Mol Cell Biol Res Commun 4: 20-25. doi:10.1006/mcbr.2000.0250. PubMed: 11152623.
105. Organisciak D, Darrow R, Gu X, Barsalou L, Crabb JW, (2006) Genetic, age and light mediated effects on crystallin protein expression in the retina. Photochem Photobiol 82: 1088-1096. doi:10.1562/2005-06-30-RA-599. PubMed: 16602829.
106. Strey CW, Spellman D, Stieber A, Gonatas JO, Wang X, et al. (2004) Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol 165: 1701-1718. doi:10.1016/S0002-9440(10)63426-8. PubMed: 15509539.
107. Mori N, Morii H, (2002) SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 70: 264-273. doi:10.1002/jnr.10353. PubMed: 12391585.
108. Cheon MS, Fountoulakis M, Cairns NJ, Dierssen M, Herkner K, et al. (2001) Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease. J Neural Transm Suppl: pp. 281-288. PubMed: 11771751.
109. Surguchov A, Palazzo RE, Surgucheva I, (2001) Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil Cytoskeleton 49: 218-228. doi:10.1002/cm.1035. PubMed: 11746666.
110. Surguchev A, Surguchov A, (2010) Conformational diseases: looking into the eyes. Brain. Res Bull 81: 12-24. doi:10.1016/j.brainresbull.2009.09.015.
111. Surgucheva I, Ninkina N, Buchman VL, Grasing K, Surguchov A, (2005) Protein aggregation in retinal cells and approaches to cell protection. Cell Mol Neurobiol 25: 1051-1066. doi:10.1007/s10571-005-8474-1. PubMed: 16392036.
112. Smith WC, Bolch S, Dugger DR, Li J, Esquenazi I, et al. (2011) Interaction of arrestin with enolase1 in photoreceptors. Invest Ophthalmol Vis Sci 52: 1832-1840. doi:10.1167/iovs.10-5724. PubMed: 21051714.
113. Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, et al. (1995) A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 10: 360-362. doi:10.1038/ng0795-360. PubMed: 7670478.
114. Klinker JF, Seifert R, (1999) Nucleoside diphosphate kinase activity in soluble transducin preparations biochemical properties and possible role of transducin-β as phosphorylated enzyme intermediate. Eur J Biochem 261: 72-80. doi:10.1046/j.1432-1327.1999.00209.x. PubMed: 10103035.
115. Orlov NY, Orlova TG, Nomura K, Hanai N, Kimura N, (1996) Transducin-mediated, isoform-specific interaction of recombinant rat nucleoside diphosphate kinases with bleached bovine retinal rod outer segment membranes. FEBS Lett 389: 186-190. doi:10.1016/0014-5793(96)00575-3. PubMed: 8766826.
116. Cuello F, Schulze RA, Heemeyer F, Meyer HE, Lutz S, et al. (2003) Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gβ subunits. Complex formation of NDPK B with Gβγ dimers and phosphorylation of His-266 in Gβ. J Biol Chem 278: 7220-7226. doi:10.1074/jbc.M210304200. PubMed: 12486123.
117. Fox DA, Poblenz AT, He L, (1999) Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. Ann N Y Acad Sci 893: 282-285. doi:10.1111/j.1749-6632.1999.tb07837.x. PubMed: 10672249.
118. Ames A III, Li YY, (1992) Energy requirements of glutamatergic pathways in rabbit retina. J Neurosci 12: 4234-4242. PubMed: 1359032.
119. Celsi F, Pizzo P, Brini M, Leo S, Fotino C, et al. (2009) Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta 1787: 335-344. doi:10.1016/j.bbabio.2009.02.021. PubMed: 19268425.
120. Kim JM, Lee KH, Jeon YJ, Oh JH, Jeong SY, et al. (2006) Identification of genes related to Parkinson's disease using expressed sequence tags. DNA Res 13: 275-286. doi:10.1093/dnares/dsl016. PubMed: 17213182.
121. Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I, (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33: 137-142. doi:10.1097/WNO.0b013e31828c4e1a. PubMed: 23612240.
122. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, et al. (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127: 737-741. doi:10.1001/archophthalmol.2009.106. PubMed: 19506190.
123. Bodis-Wollner I, Glazman S, Yerram S, (2013) Fovea and foveation in Parkinson's disease. Behav Neurosci 127: 139-150. doi:10.1037/a0031225. PubMed: 23356330.
124. Spund B, Ding Y, Liu T, Selesnick I, Glazman S, et al. (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120: 745-753. doi:10.1007/s00702-012-0909-5. PubMed: 23263598.